Propranolol: Clinical Trials

61 trials of Propranolol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 14 unknown, 5 recruiting, 5 terminated. 61 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 461Completed 31, Unknown 14, Recruiting 5, Terminated 5, Not yet recruiting 4, Enrolling by invitation 1, Withdrawn 1

Follow Propranolol: new trials by email Literature Review of Propranolol trials Research Report on Propranolol

Trials (filtered) newest first · largest first

All 61 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Propranolol, Flunarizine and Their Combination in Preventing Migraine in Adults in a Tertiary Care Hospital in Bangladesh
Propranolol 80 mg, Flunarizine 10 mg, Propranolol 40 mg + Flunarizine 10mg - Migraine Prophylaxis
Phase 4Not yet recruitingChittagong Medical College1772026-07-012026-06-22
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)
Galcanezumab, Erenumab 70 mg, Eptinezumab - Migraine Associated Vertigo, Tinnitus
Phase 4Not yet recruitingStanford University1202026-07-012026-06-17
Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery
propranolol, Usual Care - Breast Cancer, Myocardial Injury After Noncardiac Surgery (MINS)
Phase 4Not yet recruitingChang-Ik Yoon1002026-05-262026-05-15
Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices
Propranolol, Carvedilol - Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol
Phase 4Enrolling by invitationXijing Hospital3502026-01-012026-01-20
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Atogepant 60 mg, Propranolol 160 mg, Topiramate 100 mg - Migraine
Phase 4RecruitingMayo Clinic13352025-07-092026-11-13
The Effects of Propranolol and Hydrocortisone on Military-Relevant Performance Outcomes
Propranolol, Hydrocortisone, Placebo (oral) - Fear of Spiders, Acute Stress Reaction
Phase 4RecruitingWalter Reed Army Institute of Research (WRAIR)882025-05-272026-05-13
Beta-Adrenergic Modulation of Drug Cue Reactivity
Propranolol, Nicotine Patch, Placebo Propranolol - Tobacco Use Disorder, Nicotine Dependence
Phase 4RecruitingUniversity of Oklahoma802024-11-262026-04-28
Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care
Topiramate, Flunarizine, Amitriptyline - Migraine
Phase 4Not yet recruitingFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina4602024-10-012024-07-12
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
Propranolol, Placebo - Cardiovascular Disease
Phase 4RecruitingUniversity of North Carolina, Chapel Hill1202024-05-012026-11-05
Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
Phenylephrine Hydrochloride, Isoproterenol Hydrochloride, Norepinephrine Bitartrate - Vasoconstriction, Vasodilation
Phase 4RecruitingUniversity of Alberta302023-10-312026-01-08
Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With Propranolol: Effect on Psychophysiological Reactivity During Traumatic Imagery
Memory reactivation procedures, Propranolol - Stress Disorders, Post-Traumatic
Phase 4CompletedMassachusetts General Hospital312023-06-152026-11-12
Valproate Versus Propranolol in Migraine
Valproic Acid 500 MG, Propranolol - Migraine Disorders
Phase 4UnknownKafrelsheikh University6002023-01-232024-07-03
The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma
Atenolol Pill, Propranolol Pill - Spinal Tumor, Spinal Hemangioma
Phase 4UnknownCenter for Vascular Pathology, Moscow10002021-12-012021-11-03
Beta Blocker Effects in Traumatic Brain Injury
Propranolol, Saline - Trauma, Brain
Phase 4CompletedMenoufia University402021-10-012023-03-17
Impact of Beta-blockers on Physical Function in HFpEF
Beta blockers - Heart Failure, Heart Failure, Diastolic
Phase 4CompletedWeill Medical College of Cornell University92021-04-012023-09-08
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
Beta blockers - Heart Failure, Heart Failure, Diastolic
Phase 4CompletedWeill Medical College of Cornell University92021-04-012024-04-09
Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status
Placebo, Propranolol - Trauma, Brain Injuries
Phase 4UnknownHamad Medical Corporation7712020-12-292023-09-28
Pre-surgical Antisepsis of Hands After Washing With Triclosan 0.5% Compared to Propan-1-ol 60%
Triclosan 0.5 % Topical Solution, propanolol - Antisepsis
Phase 4CompletedCentro Ortopedico y Quirurgico del Pie242020-10-012020-11-02
Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)
Sirolimus Oral Product, propranolol - Hemangioendothelioma of Liver
Phase 4UnknownShanghai Children's Medical Center362020-07-012020-05-29
Surgical Hand Antisepsis With Propan-ol-1 60% Per Rubbing and Scrubbing
Hand antisepsis by scrub - Skin Diseases, Surgical Site Infection
Phase 4CompletedUniversidad Complutense de Madrid242020-06-282020-07-21

Showing 20 of 61. Sign in to see all of them.

Conditions studied

Stress Disorders, Post-Traumatic (7)  ·  Migraine Disorders (6)  ·  Esophageal and Gastric Varices (5)  ·  Hypertension, Portal (5)  ·  Liver Cirrhosis (4)  ·  Brain Injuries, Traumatic (3)  ·  Carcinoma, Hepatocellular (3)  ·  Fibrosis (3)  ·  Heart Diseases (3)  ·  Anxiety Disorders (2)  ·  Arachnophobia (2)  ·  Cardiovascular Diseases (2)  ·  Cigarette Smoking (2)  ·  Essential Tremor (2)  ·  Heart Failure (2)

Sponsors

Taipei Veterans General Hospital, Taiwan (5)  ·  Massachusetts General Hospital (4)  ·  Weill Medical College of Cornell University (3)  ·  Ain Shams University (2)  ·  Mayo Clinic (2)  ·  New York State Psychiatric Institute (2)  ·  Seoul National University Hospital (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Center for Vascular Pathology, Moscow (1)  ·  Centro Ortopedico y Quirurgico del Pie (1)  ·  Chang-Ik Yoon (1)  ·  Chittagong Medical College (1)  ·  Duke University (1)  ·  Emory University (1)  ·  Federal University of São Paulo (1)

Countries

United States (26)  ·  Taiwan (6)  ·  South Korea (4)  ·  China (3)  ·  Egypt (3)  ·  Spain (3)  ·  Bangladesh (1)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  Iran (1)  ·  Qatar (1)  ·  Russia (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Ming-Chih Hou, MD (3)  ·  Jason A Oliver, PhD (2)  ·  Parag Goyal, MD (2)  ·  Ayman El-Menyar, MD (1)  ·  Blair Simpson, MD (1)  ·  Brian J Lipworth, MD (1)  ·  Chang Ik Yoon, MD, Ph.D. (1)  ·  Charles Adler, MD, PhD (1)  ·  Craig Steinback, PhD (1)  ·  Danielle Q Bonilha, MD (1)  ·  Dmitry Romanov, MD (1)  ·  Ekaterina Listovskaia, MD (1)  ·  Fatta B Nahab, MD (1)

Results publications

PMID 11914403, PMID 12807523, PMID 20880898, PMID 21953407, PMID 22070357, PMID 22077869, PMID 22706835, PMID 24534856, PMID 25224026, PMID 25441015, PMID 27314560, PMID 28423174, PMID 29471876, PMID 29500811, PMID 30910320, PMID 31754048, PMID 33905794, PMID 34570185, PMID 34675189, PMID 34747583, PMID 34876207, PMID 34933701, PMID 35141873, PMID 36743920, PMID 37543755, PMID 38123994, PMID 38767196, PMID 39179700, PMID 40652143, PMID 40859286, PMID 8984084

NIH funding

2005 (1), K76AG064428 (1), P50MH058911 (1), R01DA053342 (1), R01HL082638 (1), R01HL157422 (1), R01MH068603 (1), R01NS073683 (1)